nodes	percent_of_prediction	percent_of_DWPC	metapath
Icosapent—PTGS1—Diphenhydramine—atopic dermatitis	0.188	0.341	CbGbCtD
Icosapent—PTGS2—Triamcinolone—atopic dermatitis	0.155	0.28	CbGbCtD
Icosapent—PTGS2—Betamethasone—atopic dermatitis	0.133	0.24	CbGbCtD
Icosapent—PTGS2—Dexamethasone—atopic dermatitis	0.0772	0.14	CbGbCtD
Icosapent—TRPV1—TRP channels—TRPV3—atopic dermatitis	0.027	0.13	CbGpPWpGaD
Icosapent—PPARG—dermis—atopic dermatitis	0.0228	0.298	CbGeAlD
Icosapent—TRPV1—Stimuli-sensing channels—TRPV3—atopic dermatitis	0.00928	0.0446	CbGpPWpGaD
Icosapent—ACSL3—head—atopic dermatitis	0.0086	0.112	CbGeAlD
Icosapent—Oropharyngeal pain—Pimecrolimus—atopic dermatitis	0.00732	0.0495	CcSEcCtD
Icosapent—SLC8A1—head—atopic dermatitis	0.00713	0.093	CbGeAlD
Icosapent—TRPV1—Ion channel transport—TRPV3—atopic dermatitis	0.00606	0.0291	CbGpPWpGaD
Icosapent—FABP7—head—atopic dermatitis	0.00524	0.0684	CbGeAlD
Icosapent—PTGS2—skin epidermis—atopic dermatitis	0.00491	0.0641	CbGeAlD
Icosapent—TRPV1—head—atopic dermatitis	0.00475	0.0621	CbGeAlD
Icosapent—FFAR1—Peptide hormone metabolism—CMA1—atopic dermatitis	0.00473	0.0227	CbGpPWpGaD
Icosapent—PPARG—neck—atopic dermatitis	0.0046	0.0601	CbGeAlD
Icosapent—ACSL4—head—atopic dermatitis	0.00432	0.0564	CbGeAlD
Icosapent—PPARD—head—atopic dermatitis	0.00414	0.0541	CbGeAlD
Icosapent—TRPV1—Trk receptor signaling mediated by PI3K and PLC-gamma—NGF—atopic dermatitis	0.00385	0.0185	CbGpPWpGaD
Icosapent—PPARG—skin of body—atopic dermatitis	0.00298	0.0389	CbGeAlD
Icosapent—PPARD—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.00293	0.0141	CbGpPWpGaD
Icosapent—Malnutrition—Pimecrolimus—atopic dermatitis	0.00291	0.0197	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL22—atopic dermatitis	0.00258	0.0124	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—CABIN1—atopic dermatitis	0.00252	0.0121	CbGpPWpGaD
Icosapent—Arthralgia—Pimecrolimus—atopic dermatitis	0.00248	0.0168	CcSEcCtD
Icosapent—Pruritus—Desonide—atopic dermatitis	0.00238	0.0161	CcSEcCtD
Icosapent—PPARD—Ectoderm Differentiation—GLB1—atopic dermatitis	0.00238	0.0114	CbGpPWpGaD
Icosapent—Anaphylactic shock—Pimecrolimus—atopic dermatitis	0.00238	0.0161	CcSEcCtD
Icosapent—PPARD—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00237	0.0114	CbGpPWpGaD
Icosapent—Oropharyngeal pain—Triamcinolone—atopic dermatitis	0.00234	0.0158	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL27—atopic dermatitis	0.0023	0.0111	CbGpPWpGaD
Icosapent—Dysgeusia—Loratadine—atopic dermatitis	0.00227	0.0154	CcSEcCtD
Icosapent—PPARG—Everolimus—Tacrolimus—atopic dermatitis	0.00221	0.149	CbGdCrCtD
Icosapent—PPARG—Everolimus—Pimecrolimus—atopic dermatitis	0.00221	0.149	CbGdCrCtD
Icosapent—SLC8A1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00218	0.0105	CbGpPWpGaD
Icosapent—PPARD—Nuclear Receptors—PPARA—atopic dermatitis	0.00217	0.0104	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Pimecrolimus—atopic dermatitis	0.00216	0.0146	CcSEcCtD
Icosapent—Dyspepsia—Dimenhydrinate—atopic dermatitis	0.00216	0.0146	CcSEcCtD
Icosapent—Dyspepsia—Diphenhydramine—atopic dermatitis	0.00216	0.0146	CcSEcCtD
Icosapent—Rash—Desonide—atopic dermatitis	0.00212	0.0143	CcSEcCtD
Icosapent—Dermatitis—Desonide—atopic dermatitis	0.00212	0.0143	CcSEcCtD
Icosapent—TRPV1—Transmembrane transport of small molecules—TRPV3—atopic dermatitis	0.00211	0.0101	CbGpPWpGaD
Icosapent—Constipation—Diphenhydramine—atopic dermatitis	0.0021	0.0142	CcSEcCtD
Icosapent—Constipation—Dimenhydrinate—atopic dermatitis	0.0021	0.0142	CcSEcCtD
Icosapent—Malnutrition—Fluocinolone Acetonide—atopic dermatitis	0.00208	0.0141	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL17—atopic dermatitis	0.00207	0.00994	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Pimecrolimus—atopic dermatitis	0.00205	0.0139	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—atopic dermatitis	0.00205	0.00984	CbGpPWpGaD
Icosapent—Dysgeusia—Fluocinolone Acetonide—atopic dermatitis	0.00204	0.0138	CcSEcCtD
Icosapent—Constipation—Pimecrolimus—atopic dermatitis	0.00203	0.0137	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—CCL22—atopic dermatitis	0.00197	0.00947	CbGpPWpGaD
Icosapent—PPARG—head—atopic dermatitis	0.00194	0.0254	CbGeAlD
Icosapent—Pruritus—Fluocinonide—atopic dermatitis	0.00193	0.013	CcSEcCtD
Icosapent—Anaphylactic shock—Loratadine—atopic dermatitis	0.00189	0.0128	CcSEcCtD
Icosapent—FFAR1—G alpha (q) signalling events—NPS—atopic dermatitis	0.00183	0.00879	CbGpPWpGaD
Icosapent—FFAR1—G alpha (q) signalling events—TAC1—atopic dermatitis	0.00183	0.00879	CbGpPWpGaD
Icosapent—FADS1—PPARA activates gene expression—PPARA—atopic dermatitis	0.00182	0.00876	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.0018	0.00865	CbGpPWpGaD
Icosapent—FADS1—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	0.00178	0.00857	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—STAT6—atopic dermatitis	0.00178	0.00855	CbGpPWpGaD
Icosapent—Arthralgia—Fluocinolone Acetonide—atopic dermatitis	0.00177	0.012	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—CCL27—atopic dermatitis	0.00175	0.00844	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Loratadine—atopic dermatitis	0.00172	0.0117	CcSEcCtD
Icosapent—Rash—Fluocinonide—atopic dermatitis	0.00172	0.0116	CcSEcCtD
Icosapent—Dermatitis—Fluocinonide—atopic dermatitis	0.00172	0.0116	CcSEcCtD
Icosapent—PPARD—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.00171	0.00823	CbGpPWpGaD
Icosapent—PTGS2—Fluocinonide—Desonide—atopic dermatitis	0.00171	0.116	CbGdCrCtD
Icosapent—Arthralgia—Mometasone—atopic dermatitis	0.00169	0.0115	CcSEcCtD
Icosapent—Pruritus—Pimecrolimus—atopic dermatitis	0.00168	0.0114	CcSEcCtD
Icosapent—Dyspepsia—Loratadine—atopic dermatitis	0.00167	0.0113	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL11—atopic dermatitis	0.00167	0.00801	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—NPS—atopic dermatitis	0.00163	0.00786	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—TAC1—atopic dermatitis	0.00163	0.00786	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Loratadine—atopic dermatitis	0.00163	0.011	CcSEcCtD
Icosapent—Anaphylactic shock—Mometasone—atopic dermatitis	0.00162	0.011	CcSEcCtD
Icosapent—Constipation—Loratadine—atopic dermatitis	0.00162	0.0109	CcSEcCtD
Icosapent—PPARG—RXR and RAR heterodimerization with other nuclear receptor—PPARA—atopic dermatitis	0.0016	0.0077	CbGpPWpGaD
Icosapent—PTGS1—skin of body—atopic dermatitis	0.00159	0.0208	CbGeAlD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—CCR3—atopic dermatitis	0.00158	0.00762	CbGpPWpGaD
Icosapent—Malnutrition—Tacrolimus—atopic dermatitis	0.00158	0.0107	CcSEcCtD
Icosapent—SLC8A1—SLC-mediated transmembrane transport—SLC11A1—atopic dermatitis	0.00158	0.00758	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CCL17—atopic dermatitis	0.00157	0.00757	CbGpPWpGaD
Icosapent—Vomiting—Dimenhydrinate—atopic dermatitis	0.00156	0.0106	CcSEcCtD
Icosapent—Vomiting—Diphenhydramine—atopic dermatitis	0.00156	0.0106	CcSEcCtD
Icosapent—Dysgeusia—Tacrolimus—atopic dermatitis	0.00155	0.0105	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Fluocinolone Acetonide—atopic dermatitis	0.00155	0.0105	CcSEcCtD
Icosapent—Rash—Diphenhydramine—atopic dermatitis	0.00155	0.0105	CcSEcCtD
Icosapent—Rash—Dimenhydrinate—atopic dermatitis	0.00155	0.0105	CcSEcCtD
Icosapent—Dermatitis—Diphenhydramine—atopic dermatitis	0.00155	0.0105	CcSEcCtD
Icosapent—Dermatitis—Dimenhydrinate—atopic dermatitis	0.00155	0.0105	CcSEcCtD
Icosapent—PTGS2—skin of body—atopic dermatitis	0.00152	0.0199	CbGeAlD
Icosapent—Vomiting—Pimecrolimus—atopic dermatitis	0.00151	0.0102	CcSEcCtD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00151	0.00725	CbGpPWpGaD
Icosapent—Rash—Pimecrolimus—atopic dermatitis	0.0015	0.0101	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—atopic dermatitis	0.0015	0.0072	CbGpPWpGaD
Icosapent—Dermatitis—Pimecrolimus—atopic dermatitis	0.0015	0.0101	CcSEcCtD
Icosapent—PPARG—Circadian rythm related genes—RELB—atopic dermatitis	0.00149	0.00717	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Mometasone—atopic dermatitis	0.00148	0.01	CcSEcCtD
Icosapent—Gastrointestinal disorder—Fluocinolone Acetonide—atopic dermatitis	0.00147	0.00993	CcSEcCtD
Icosapent—ACSL3—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.00147	0.00705	CbGpPWpGaD
Icosapent—Alanine aminotransferase increased—Hydrocortisone—atopic dermatitis	0.00145	0.00978	CcSEcCtD
Icosapent—Dyspepsia—Mometasone—atopic dermatitis	0.00143	0.00967	CcSEcCtD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—CXCR3—atopic dermatitis	0.00139	0.00666	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.00136	0.00655	CbGpPWpGaD
Icosapent—Alanine aminotransferase increased—Methylprednisolone—atopic dermatitis	0.00136	0.00919	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCR3—atopic dermatitis	0.00136	0.00653	CbGpPWpGaD
Icosapent—Arthralgia—Tacrolimus—atopic dermatitis	0.00135	0.00912	CcSEcCtD
Icosapent—PTGS2—Fluocinonide—Fluocinolone Acetonide—atopic dermatitis	0.00133	0.09	CbGdCrCtD
Icosapent—PPARG—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARA—atopic dermatitis	0.00129	0.00622	CbGpPWpGaD
Icosapent—Anaphylactic shock—Tacrolimus—atopic dermatitis	0.00129	0.00874	CcSEcCtD
Icosapent—PPARD—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.00129	0.00619	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CCL11—atopic dermatitis	0.00127	0.0061	CbGpPWpGaD
Icosapent—FADS1—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.00123	0.0059	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—TAC1—atopic dermatitis	0.00121	0.00582	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—NPS—atopic dermatitis	0.00121	0.00582	CbGpPWpGaD
Icosapent—Pruritus—Fluocinolone Acetonide—atopic dermatitis	0.0012	0.00814	CcSEcCtD
Icosapent—Vomiting—Loratadine—atopic dermatitis	0.0012	0.00814	CcSEcCtD
Icosapent—Rash—Loratadine—atopic dermatitis	0.00119	0.00807	CcSEcCtD
Icosapent—Dermatitis—Loratadine—atopic dermatitis	0.00119	0.00806	CcSEcCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CXCR3—atopic dermatitis	0.00119	0.00571	CbGpPWpGaD
Icosapent—PPARG—Nuclear Receptors—PPARA—atopic dermatitis	0.00118	0.00569	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Tacrolimus—atopic dermatitis	0.00118	0.00796	CcSEcCtD
Icosapent—FFAR1—Metabolism of proteins—GLB1—atopic dermatitis	0.00118	0.00566	CbGpPWpGaD
Icosapent—PTGS2—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—NFKBIA—atopic dermatitis	0.00116	0.00559	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—KIF3A—atopic dermatitis	0.00116	0.00557	CbGpPWpGaD
Icosapent—Pruritus—Mometasone—atopic dermatitis	0.00115	0.00777	CcSEcCtD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FOXP3—atopic dermatitis	0.00114	0.00547	CbGpPWpGaD
Icosapent—Dyspepsia—Tacrolimus—atopic dermatitis	0.00114	0.00769	CcSEcCtD
Icosapent—Gastrointestinal disorder—Tacrolimus—atopic dermatitis	0.00112	0.00755	CcSEcCtD
Icosapent—ACSL4—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.00111	0.00534	CbGpPWpGaD
Icosapent—Constipation—Tacrolimus—atopic dermatitis	0.00111	0.00747	CcSEcCtD
Icosapent—Vomiting—Fluocinolone Acetonide—atopic dermatitis	0.00108	0.00731	CcSEcCtD
Icosapent—Alanine aminotransferase increased—Prednisone—atopic dermatitis	0.00108	0.00728	CcSEcCtD
Icosapent—Rash—Fluocinolone Acetonide—atopic dermatitis	0.00107	0.00725	CcSEcCtD
Icosapent—Dermatitis—Fluocinolone Acetonide—atopic dermatitis	0.00107	0.00724	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—atopic dermatitis	0.00107	0.00512	CbGpPWpGaD
Icosapent—PTGS2—Fluocinonide—Mometasone—atopic dermatitis	0.00106	0.0718	CbGdCrCtD
Icosapent—PTGS1—head—atopic dermatitis	0.00104	0.0136	CbGeAlD
Icosapent—FFAR1—GPCR ligand binding—CCR3—atopic dermatitis	0.00103	0.00497	CbGpPWpGaD
Icosapent—Vomiting—Mometasone—atopic dermatitis	0.00103	0.00698	CcSEcCtD
Icosapent—Rash—Mometasone—atopic dermatitis	0.00102	0.00692	CcSEcCtD
Icosapent—Dermatitis—Mometasone—atopic dermatitis	0.00102	0.00692	CcSEcCtD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—MAPK8—atopic dermatitis	0.00102	0.00489	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL22—atopic dermatitis	0.00101	0.00486	CbGpPWpGaD
Icosapent—PTGS2—head—atopic dermatitis	0.000992	0.013	CbGeAlD
Icosapent—FFAR1—GPCR downstream signaling—CCL27—atopic dermatitis	0.000991	0.00477	CbGpPWpGaD
Icosapent—Malnutrition—Hydrocortisone—atopic dermatitis	0.000988	0.00668	CcSEcCtD
Icosapent—PPARG—Adipogenesis—STAT6—atopic dermatitis	0.000971	0.00467	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CXCL10—atopic dermatitis	0.000959	0.00461	CbGpPWpGaD
Icosapent—PPARG—Nuclear Receptor transcription pathway—PPARA—atopic dermatitis	0.000935	0.00449	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—SELE—atopic dermatitis	0.000933	0.00449	CbGpPWpGaD
Icosapent—Malnutrition—Methylprednisolone—atopic dermatitis	0.000928	0.00628	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—NPS—atopic dermatitis	0.000922	0.00443	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—TAC1—atopic dermatitis	0.000922	0.00443	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL4—atopic dermatitis	0.000916	0.0044	CbGpPWpGaD
Icosapent—Pruritus—Tacrolimus—atopic dermatitis	0.000914	0.00618	CcSEcCtD
Icosapent—Dysgeusia—Triamcinolone—atopic dermatitis	0.000911	0.00616	CcSEcCtD
Icosapent—PTGS1—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.00091	0.00437	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CXCR3—atopic dermatitis	0.000904	0.00435	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL27—atopic dermatitis	0.0009	0.00433	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—CMA1—atopic dermatitis	0.000892	0.00429	CbGpPWpGaD
Icosapent—FFAR1—GPCRs, Class A Rhodopsin-like—CCR5—atopic dermatitis	0.000868	0.00418	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL5—atopic dermatitis	0.000833	0.00401	CbGpPWpGaD
Icosapent—PTGS2—Fluticasone Propionate—Fluocinonide—atopic dermatitis	0.000827	0.0559	CbGdCrCtD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCL5—atopic dermatitis	0.000826	0.00397	CbGpPWpGaD
Icosapent—Anaphylactic shock—Prednisolone—atopic dermatitis	0.000826	0.00558	CcSEcCtD
Icosapent—Vomiting—Tacrolimus—atopic dermatitis	0.000822	0.00556	CcSEcCtD
Icosapent—Rash—Tacrolimus—atopic dermatitis	0.000815	0.00551	CcSEcCtD
Icosapent—Dermatitis—Tacrolimus—atopic dermatitis	0.000814	0.00551	CcSEcCtD
Icosapent—PPARD—Adipogenesis—PPARA—atopic dermatitis	0.00081	0.00389	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL17—atopic dermatitis	0.000808	0.00388	CbGpPWpGaD
Icosapent—Anaphylactic shock—Hydrocortisone—atopic dermatitis	0.000806	0.00545	CcSEcCtD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—TNF—atopic dermatitis	0.000804	0.00387	CbGpPWpGaD
Icosapent—PTGS2—Fluticasone Propionate—Fluocinolone Acetonide—atopic dermatitis	0.000803	0.0543	CbGdCrCtD
Icosapent—SLC8A1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000801	0.00385	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—GLB1—atopic dermatitis	0.000801	0.00385	CbGpPWpGaD
Icosapent—Arthralgia—Methylprednisolone—atopic dermatitis	0.00079	0.00534	CcSEcCtD
Icosapent—TRPV1—Transmembrane transport of small molecules—SLC11A1—atopic dermatitis	0.000774	0.00372	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—ADSL—atopic dermatitis	0.000768	0.00369	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000766	0.00368	CbGpPWpGaD
Icosapent—Anaphylactic shock—Triamcinolone—atopic dermatitis	0.000759	0.00513	CcSEcCtD
Icosapent—Anaphylactic shock—Methylprednisolone—atopic dermatitis	0.000758	0.00512	CcSEcCtD
Icosapent—PPARG—Noncanonical Wnt signaling pathway—MAPK8—atopic dermatitis	0.000753	0.00362	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CCR5—atopic dermatitis	0.000744	0.00358	CbGpPWpGaD
Icosapent—Malnutrition—Prednisone—atopic dermatitis	0.000735	0.00497	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Hydrocortisone—atopic dermatitis	0.000735	0.00497	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—CXCL10—atopic dermatitis	0.000731	0.00351	CbGpPWpGaD
Icosapent—PTGS2—Overview of nanoparticle effects—CXCL8—atopic dermatitis	0.000722	0.00347	CbGpPWpGaD
Icosapent—Dyspepsia—Hydrocortisone—atopic dermatitis	0.00071	0.0048	CcSEcCtD
Icosapent—SLC8A1—Hemostasis—IL5—atopic dermatitis	0.000707	0.0034	CbGpPWpGaD
Icosapent—PPARG—RXR and RAR heterodimerization with other nuclear receptor—TNF—atopic dermatitis	0.000703	0.00338	CbGpPWpGaD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL1B—atopic dermatitis	0.000699	0.00336	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Hydrocortisone—atopic dermatitis	0.000696	0.00471	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Triamcinolone—atopic dermatitis	0.000692	0.00468	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Methylprednisolone—atopic dermatitis	0.00069	0.00467	CcSEcCtD
Icosapent—Anaphylactic shock—Betamethasone—atopic dermatitis	0.000689	0.00466	CcSEcCtD
Icosapent—Anaphylactic shock—Dexamethasone—atopic dermatitis	0.000689	0.00466	CcSEcCtD
Icosapent—PPARG—Transcriptional regulation of white adipocyte differentiation—PPARA—atopic dermatitis	0.000672	0.00323	CbGpPWpGaD
Icosapent—FADS1—Metabolism—GLB1—atopic dermatitis	0.000671	0.00323	CbGpPWpGaD
Icosapent—Dyspepsia—Triamcinolone—atopic dermatitis	0.000668	0.00452	CcSEcCtD
Icosapent—Dyspepsia—Methylprednisolone—atopic dermatitis	0.000667	0.00451	CcSEcCtD
Icosapent—FFAR1—Signaling by GPCR—CCL11—atopic dermatitis	0.000651	0.00313	CbGpPWpGaD
Icosapent—PPARG—Transcription factor regulation in adipogenesis—IL6—atopic dermatitis	0.000649	0.00312	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	0.000644	0.0031	CbGpPWpGaD
Icosapent—FADS1—Metabolism—ADSL—atopic dermatitis	0.000643	0.00309	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—FCER2—atopic dermatitis	0.000642	0.00309	CbGpPWpGaD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—NFKBIA—atopic dermatitis	0.000641	0.00308	CbGpPWpGaD
Icosapent—PTGS2—Fluticasone Propionate—Mometasone—atopic dermatitis	0.000641	0.0433	CbGdCrCtD
Icosapent—PTGS2—Fluocinonide—Methylprednisolone—atopic dermatitis	0.000634	0.0429	CbGdCrCtD
Icosapent—PTGS1—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000633	0.00304	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CCL5—atopic dermatitis	0.000629	0.00302	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Betamethasone—atopic dermatitis	0.000628	0.00424	CcSEcCtD
Icosapent—Musculoskeletal discomfort—Dexamethasone—atopic dermatitis	0.000628	0.00424	CcSEcCtD
Icosapent—Arthralgia—Prednisone—atopic dermatitis	0.000626	0.00423	CcSEcCtD
Icosapent—PTGS2—Fluocinonide—Dexamethasone—atopic dermatitis	0.000624	0.0422	CbGdCrCtD
Icosapent—PTGS2—Fluocinonide—Betamethasone—atopic dermatitis	0.000624	0.0422	CbGdCrCtD
Icosapent—PPARD—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000624	0.003	CbGpPWpGaD
Icosapent—PTGS2—Fluocinonide—Triamcinolone—atopic dermatitis	0.00061	0.0412	CbGdCrCtD
Icosapent—ACSL4—Metabolism—GLB1—atopic dermatitis	0.000607	0.00292	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—GLB1—atopic dermatitis	0.000607	0.00292	CbGpPWpGaD
Icosapent—Dyspepsia—Betamethasone—atopic dermatitis	0.000606	0.0041	CcSEcCtD
Icosapent—Dyspepsia—Dexamethasone—atopic dermatitis	0.000606	0.0041	CcSEcCtD
Icosapent—Anaphylactic shock—Prednisone—atopic dermatitis	0.0006	0.00406	CcSEcCtD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	0.000599	0.00288	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL22—atopic dermatitis	0.000597	0.00287	CbGpPWpGaD
Icosapent—Gastrointestinal disorder—Betamethasone—atopic dermatitis	0.000595	0.00402	CcSEcCtD
Icosapent—Gastrointestinal disorder—Dexamethasone—atopic dermatitis	0.000595	0.00402	CcSEcCtD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—atopic dermatitis	0.000592	0.00285	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CCR3—atopic dermatitis	0.000584	0.00281	CbGpPWpGaD
Icosapent—ACSL3—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000583	0.00281	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—ADSL—atopic dermatitis	0.000582	0.0028	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—ADSL—atopic dermatitis	0.000582	0.0028	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	0.000572	0.00275	CbGpPWpGaD
Icosapent—Pruritus—Hydrocortisone—atopic dermatitis	0.00057	0.00386	CcSEcCtD
Icosapent—FFAR1—GPCR ligand binding—CCR5—atopic dermatitis	0.000567	0.00272	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—atopic dermatitis	0.000554	0.00266	CbGpPWpGaD
Icosapent—Musculoskeletal discomfort—Prednisone—atopic dermatitis	0.000547	0.0037	CcSEcCtD
Icosapent—Pruritus—Triamcinolone—atopic dermatitis	0.000537	0.00363	CcSEcCtD
Icosapent—Pruritus—Methylprednisolone—atopic dermatitis	0.000536	0.00362	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—CCL27—atopic dermatitis	0.000532	0.00256	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCR3—atopic dermatitis	0.000531	0.00255	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—NPS—atopic dermatitis	0.000529	0.00255	CbGpPWpGaD
Icosapent—Dyspepsia—Prednisone—atopic dermatitis	0.000528	0.00357	CcSEcCtD
Icosapent—FFAR1—GPCR downstream signaling—NPS—atopic dermatitis	0.000521	0.0025	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—TAC1—atopic dermatitis	0.000521	0.0025	CbGpPWpGaD
Icosapent—Rash—Prednisolone—atopic dermatitis	0.000521	0.00352	CcSEcCtD
Icosapent—Dermatitis—Prednisolone—atopic dermatitis	0.00052	0.00352	CcSEcCtD
Icosapent—Constipation—Prednisone—atopic dermatitis	0.000513	0.00347	CcSEcCtD
Icosapent—Vomiting—Hydrocortisone—atopic dermatitis	0.000513	0.00347	CcSEcCtD
Icosapent—PTGS1—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000511	0.00246	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CXCR3—atopic dermatitis	0.000511	0.00246	CbGpPWpGaD
Icosapent—PPARG—Wnt Signaling Pathway Netpath—MAPK8—atopic dermatitis	0.00051	0.00245	CbGpPWpGaD
Icosapent—Rash—Hydrocortisone—atopic dermatitis	0.000508	0.00344	CcSEcCtD
Icosapent—Dermatitis—Hydrocortisone—atopic dermatitis	0.000508	0.00343	CcSEcCtD
Icosapent—PPARG—PPARA activates gene expression—PPARA—atopic dermatitis	0.000505	0.00243	CbGpPWpGaD
Icosapent—PTGS2—Overview of nanoparticle effects—TNF—atopic dermatitis	0.000503	0.00242	CbGpPWpGaD
Icosapent—PPARG—Regulation of lipid metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha)—PPARA—atopic dermatitis	0.000495	0.00238	CbGpPWpGaD
Icosapent—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—atopic dermatitis	0.000492	0.00237	CbGpPWpGaD
Icosapent—FADS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000489	0.00235	CbGpPWpGaD
Icosapent—Pruritus—Betamethasone—atopic dermatitis	0.000487	0.0033	CcSEcCtD
Icosapent—Pruritus—Dexamethasone—atopic dermatitis	0.000487	0.0033	CcSEcCtD
Icosapent—FFAR1—GPCR downstream signaling—IL5—atopic dermatitis	0.000484	0.00233	CbGpPWpGaD
Icosapent—Vomiting—Triamcinolone—atopic dermatitis	0.000483	0.00326	CcSEcCtD
Icosapent—Vomiting—Methylprednisolone—atopic dermatitis	0.000482	0.00326	CcSEcCtD
Icosapent—Rash—Triamcinolone—atopic dermatitis	0.000479	0.00324	CcSEcCtD
Icosapent—Dermatitis—Triamcinolone—atopic dermatitis	0.000478	0.00323	CcSEcCtD
Icosapent—Rash—Methylprednisolone—atopic dermatitis	0.000478	0.00323	CcSEcCtD
Icosapent—Dermatitis—Methylprednisolone—atopic dermatitis	0.000477	0.00323	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—CCL17—atopic dermatitis	0.000477	0.00229	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—NPS—atopic dermatitis	0.000473	0.00227	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—TAC1—atopic dermatitis	0.000473	0.00227	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CXCR3—atopic dermatitis	0.000464	0.00223	CbGpPWpGaD
Icosapent—FFAR1—Class A/1 (Rhodopsin-like receptors)—CXCL8—atopic dermatitis	0.00045	0.00216	CbGpPWpGaD
Icosapent—ACSL4—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000442	0.00213	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—PPARA—atopic dermatitis	0.000442	0.00213	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL5—atopic dermatitis	0.00044	0.00211	CbGpPWpGaD
Icosapent—Vomiting—Betamethasone—atopic dermatitis	0.000438	0.00296	CcSEcCtD
Icosapent—Vomiting—Dexamethasone—atopic dermatitis	0.000438	0.00296	CcSEcCtD
Icosapent—Rash—Dexamethasone—atopic dermatitis	0.000434	0.00294	CcSEcCtD
Icosapent—Rash—Betamethasone—atopic dermatitis	0.000434	0.00294	CcSEcCtD
Icosapent—Dermatitis—Betamethasone—atopic dermatitis	0.000434	0.00293	CcSEcCtD
Icosapent—Dermatitis—Dexamethasone—atopic dermatitis	0.000434	0.00293	CcSEcCtD
Icosapent—FFAR1—Signaling Pathways—KIF3A—atopic dermatitis	0.000425	0.00204	CbGpPWpGaD
Icosapent—Pruritus—Prednisone—atopic dermatitis	0.000424	0.00287	CcSEcCtD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000418	0.00201	CbGpPWpGaD
Icosapent—PPARG—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	0.000417	0.002	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CXCL10—atopic dermatitis	0.000413	0.00199	CbGpPWpGaD
Icosapent—SLC8A1—Myometrial Relaxation and Contraction Pathways—IL6—atopic dermatitis	0.000409	0.00197	CbGpPWpGaD
Icosapent—PTGS2—Overview of nanoparticle effects—IL6—atopic dermatitis	0.000406	0.00195	CbGpPWpGaD
Icosapent—SLC8A1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000388	0.00187	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CMA1—atopic dermatitis	0.000385	0.00185	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL11—atopic dermatitis	0.000385	0.00185	CbGpPWpGaD
Icosapent—PTGS2—Fluticasone Propionate—Methylprednisolone—atopic dermatitis	0.000383	0.0259	CbGdCrCtD
Icosapent—Vomiting—Prednisone—atopic dermatitis	0.000381	0.00258	CcSEcCtD
Icosapent—Rash—Prednisone—atopic dermatitis	0.000378	0.00256	CcSEcCtD
Icosapent—Dermatitis—Prednisone—atopic dermatitis	0.000378	0.00256	CcSEcCtD
Icosapent—PTGS2—Fluticasone Propionate—Dexamethasone—atopic dermatitis	0.000377	0.0255	CbGdCrCtD
Icosapent—PTGS2—Fluticasone Propionate—Betamethasone—atopic dermatitis	0.000377	0.0255	CbGdCrCtD
Icosapent—FFAR1—Signaling by GPCR—CXCL10—atopic dermatitis	0.000375	0.0018	CbGpPWpGaD
Icosapent—TRPV1—Transmembrane transport of small molecules—PPARA—atopic dermatitis	0.000375	0.0018	CbGpPWpGaD
Icosapent—PTGS2—Fluticasone Propionate—Triamcinolone—atopic dermatitis	0.000368	0.0249	CbGdCrCtD
Icosapent—FFAR1—Signaling Pathways—STAT6—atopic dermatitis	0.000362	0.00174	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—atopic dermatitis	0.000358	0.00172	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CXCL10—atopic dermatitis	0.000357	0.00172	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—TNF—atopic dermatitis	0.000355	0.00171	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CCL5—atopic dermatitis	0.000355	0.00171	CbGpPWpGaD
Icosapent—FFAR1—GPCR ligand binding—CXCL8—atopic dermatitis	0.000343	0.00165	CbGpPWpGaD
Icosapent—FFAR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—atopic dermatitis	0.000341	0.00164	CbGpPWpGaD
Icosapent—PPARD—Metabolism—GLB1—atopic dermatitis	0.000341	0.00164	CbGpPWpGaD
Icosapent—PPARG—Fatty acid, triacylglycerol, and ketone body metabolism—PPARA—atopic dermatitis	0.000341	0.00164	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—atopic dermatitis	0.000333	0.0016	CbGpPWpGaD
Icosapent—PPARD—Metabolism—ADSL—atopic dermatitis	0.000327	0.00157	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCL5—atopic dermatitis	0.000323	0.00155	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—BDNF—atopic dermatitis	0.000321	0.00154	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CCR5—atopic dermatitis	0.00032	0.00154	CbGpPWpGaD
Icosapent—PPARG—Signaling events mediated by HDAC Class I—TNF—atopic dermatitis	0.000318	0.00153	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—atopic dermatitis	0.000318	0.00153	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCR3—atopic dermatitis	0.000313	0.00151	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—PPARA—atopic dermatitis	0.000312	0.0015	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL4—atopic dermatitis	0.000298	0.00143	CbGpPWpGaD
Icosapent—PPARD—Generic Transcription Pathway—PPARA—atopic dermatitis	0.000296	0.00142	CbGpPWpGaD
Icosapent—PPARG—Transcriptional regulation of white adipocyte differentiation—TNF—atopic dermatitis	0.000295	0.00142	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000293	0.00141	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CCR5—atopic dermatitis	0.000291	0.0014	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000287	0.00138	CbGpPWpGaD
Icosapent—PPARD—Adipogenesis—IL6—atopic dermatitis	0.000287	0.00138	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—TAC1—atopic dermatitis	0.000279	0.00134	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NPS—atopic dermatitis	0.000279	0.00134	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCR3—atopic dermatitis	0.000274	0.00132	CbGpPWpGaD
Icosapent—SLC8A1—Hemostasis—IL2—atopic dermatitis	0.00027	0.0013	CbGpPWpGaD
Icosapent—ACSL3—Metabolism—PPARA—atopic dermatitis	0.00026	0.00125	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL5—atopic dermatitis	0.00026	0.00125	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000256	0.00123	CbGpPWpGaD
Icosapent—PPARD—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000249	0.0012	CbGpPWpGaD
Icosapent—PTGS2—Aryl Hydrocarbon Receptor—TNF—atopic dermatitis	0.000248	0.00119	CbGpPWpGaD
Icosapent—FFAR1—Metabolism of proteins—CXCL8—atopic dermatitis	0.000241	0.00116	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—GLB1—atopic dermatitis	0.000233	0.00112	CbGpPWpGaD
Icosapent—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—atopic dermatitis	0.000232	0.00111	CbGpPWpGaD
Icosapent—PTGS2—C-MYB transcription factor network—CD4—atopic dermatitis	0.000228	0.0011	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—IFNG—atopic dermatitis	0.000228	0.0011	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCL10—atopic dermatitis	0.000221	0.00107	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—BDNF—atopic dermatitis	0.000218	0.00105	CbGpPWpGaD
Icosapent—FADS1—Metabolism—PPARA—atopic dermatitis	0.000218	0.00105	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—IL1B—atopic dermatitis	0.000203	0.000977	CbGpPWpGaD
Icosapent—FFAR1—Metabolism—PPARA—atopic dermatitis	0.000197	0.000947	CbGpPWpGaD
Icosapent—ACSL4—Metabolism—PPARA—atopic dermatitis	0.000197	0.000947	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—TNF—atopic dermatitis	0.000194	0.000933	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—CXCL8—atopic dermatitis	0.000194	0.000931	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCL5—atopic dermatitis	0.000191	0.000917	CbGpPWpGaD
Icosapent—PPARG—Metabolism—GLB1—atopic dermatitis	0.000186	0.000896	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000186	0.000893	CbGpPWpGaD
Icosapent—FFAR1—GPCR downstream signaling—IL2—atopic dermatitis	0.000185	0.00089	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IFNG—atopic dermatitis	0.00018	0.000866	CbGpPWpGaD
Icosapent—PPARG—Metabolism—ADSL—atopic dermatitis	0.000179	0.000859	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NGF—atopic dermatitis	0.000177	0.000849	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—CXCL8—atopic dermatitis	0.000176	0.000845	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—MAPK8—atopic dermatitis	0.000173	0.000832	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CCR5—atopic dermatitis	0.000172	0.000826	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL2—atopic dermatitis	0.000168	0.000808	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—CXCL8—atopic dermatitis	0.000168	0.000806	CbGpPWpGaD
Icosapent—PPARG—Generic Transcription Pathway—PPARA—atopic dermatitis	0.000161	0.000776	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL1B—atopic dermatitis	0.000161	0.000773	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL2—atopic dermatitis	0.00016	0.00077	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—NFKBIA—atopic dermatitis	0.00016	0.000768	CbGpPWpGaD
Icosapent—PPARG—Adipogenesis—IL6—atopic dermatitis	0.000157	0.000753	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—PPARA—atopic dermatitis	0.000152	0.000731	CbGpPWpGaD
Icosapent—PTGS1—Selenium Micronutrient Network—IL6—atopic dermatitis	0.00015	0.000721	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—TNF—atopic dermatitis	0.000147	0.000709	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—NFKBIA—atopic dermatitis	0.000146	0.0007	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—atopic dermatitis	0.000144	0.000693	CbGpPWpGaD
Icosapent—PPARD—Gene Expression—PPARA—atopic dermatitis	0.000142	0.000685	CbGpPWpGaD
Icosapent—PPARG—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	0.000136	0.000653	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—GLB1—atopic dermatitis	0.00013	0.000627	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—ADSL—atopic dermatitis	0.000125	0.000601	CbGpPWpGaD
Icosapent—PTGS2—Disease—GLB1—atopic dermatitis	0.000124	0.000595	CbGpPWpGaD
Icosapent—PTGS2—Selenium Micronutrient Network—IL6—atopic dermatitis	0.000119	0.000572	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—TNF—atopic dermatitis	0.000117	0.000561	CbGpPWpGaD
Icosapent—PPARD—Metabolism—PPARA—atopic dermatitis	0.000111	0.000532	CbGpPWpGaD
Icosapent—PPARG—Circadian rythm related genes—IL6—atopic dermatitis	0.000111	0.000531	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—CXCL8—atopic dermatitis	0.000104	0.000499	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—GLB1—atopic dermatitis	0.000104	0.000498	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—atopic dermatitis	0.0001	0.000482	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—ADSL—atopic dermatitis	9.93e-05	0.000477	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL2—atopic dermatitis	9.92e-05	0.000477	CbGpPWpGaD
Icosapent—FFAR1—Signaling by GPCR—IL6—atopic dermatitis	9.87e-05	0.000475	CbGpPWpGaD
Icosapent—PTGS1—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	9.51e-05	0.000457	CbGpPWpGaD
Icosapent—PTGS2—Spinal Cord Injury—IL6—atopic dermatitis	9.41e-05	0.000453	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—MAPK8—atopic dermatitis	9.13e-05	0.000439	CbGpPWpGaD
Icosapent—PTGS2—Disease—SLC11A1—atopic dermatitis	8.28e-05	0.000398	CbGpPWpGaD
Icosapent—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—atopic dermatitis	7.93e-05	0.000381	CbGpPWpGaD
Icosapent—PPARG—Gene Expression—PPARA—atopic dermatitis	7.77e-05	0.000374	CbGpPWpGaD
Icosapent—PTGS2—Metabolism of lipids and lipoproteins—PPARA—atopic dermatitis	7.55e-05	0.000363	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—TNF—atopic dermatitis	6.67e-05	0.000321	CbGpPWpGaD
Icosapent—PPARG—Metabolism—PPARA—atopic dermatitis	6.04e-05	0.000291	CbGpPWpGaD
Icosapent—FFAR1—Signaling Pathways—IL6—atopic dermatitis	5.83e-05	0.000281	CbGpPWpGaD
Icosapent—PPARG—Developmental Biology—IL6—atopic dermatitis	5.38e-05	0.000259	CbGpPWpGaD
Icosapent—PTGS1—Metabolism—PPARA—atopic dermatitis	4.23e-05	0.000204	CbGpPWpGaD
Icosapent—PTGS2—Disease—CCR5—atopic dermatitis	4.19e-05	0.000201	CbGpPWpGaD
Icosapent—PTGS2—Metabolism—PPARA—atopic dermatitis	3.36e-05	0.000162	CbGpPWpGaD
Icosapent—PTGS2—Disease—CD4—atopic dermatitis	2.63e-05	0.000126	CbGpPWpGaD
Icosapent—PTGS2—Disease—IL6—atopic dermatitis	1.42e-05	6.84e-05	CbGpPWpGaD
